| -abine | (see -arabine, -citabine) | decitabine |
| -ac | Anti-inflammatory agents (acetic acid derivatives) | bromfenac; dexpemedolac |
| -acetam | See -racetam | |
| -actide | Synthetic corticotropins | seractide |
| -adol or -aldol- | Analgesics (mixed opiate receptor agonists/ antagonists) | tazadolene; spiradolene; levonantradol |
| -adox | Antibacterials (quinoline dioxide derivatives) | carbadox |
| -afenone | Antiarrhythmics (propafenone derivatives) | alprafenone; diprafenone |
| -afil | PDE5 inhibitors | tadalafil |
| -aj- | Antiarrhythmics (ajmaline derivatives) | lorajmine |
| -aldrate | Antacid aluminum salts | magaldrate |
| -algron | Alpha1 - and alpha2 - adrenoreceptor agonists | dabuzalgron |
| -alol | Combined alpha and beta blockers | labetalol; medroxalol |
| -amivir | (see -vir) | |
| -ampa | Ionotropic non-NMDA glutamate receptors (AMPA and/or KA receptors) | |
| subgroups: |
| -ampanel | Ionotropic non-NMDA glutamate receptors (AMPA and/or KA receptors); antagonists | becampanel |
| -ampator | Ionotropic non-NMDA glutamate receptors (AMPA and/or KA receptors); modulators | forampator |
| -andr- | Androgens | nandrolone |
| -anib | Angiogenesis inhibitors | semaxanib |
| -anserin | Serotonin 5-HT2 receptor antagonists | altanserin; tropanserin; adatanserin |
| -antel | Anthelmintics (undefined group) | carbantel |
| -antrone | Antineoplastics; anthraquinone derivatives | pixantrone |
| -apsel | P-selectin antagonists | torapsel |
| -arabine | Antineoplastics (arabinofuranosyl derivatives) | fazarabine; fludarabine |
| aril-, -aril, -aril- | Antiviral (arildone derivatives) | pleconaril; arildone; fosarilate |
| -arit | Antirheumatics (lobenzarit type) | lobenzarit; clobuzarit |
| -arol | Anticoagulants (dicumarol type) | dicumarol |
| -arone | Antiarrhythmics | amiodarone; dronedarone |
| -arot- | Arotinoids | etarotene; sumarotene; tazarotene |
| subgroup: |
| -arotene | Arotinoid derivatives | bexarotene; linarotene; tazarotene |
| arte- | Antimalarials (artemisin derivatives) | arteflene |
| -ase | Enzymes | alglucerase; dornase alfa |
| subgroups: |
| -dismase | Enzymes; superoxide dismutase activity (exception: orgotein) | sudismase |
| -teplase | Enzymes; tissue-type plasminogen activators | alteplase; duteplase; silteplase |
| -uplase | Enzymes; urokinase-type plasminogen activators | saruplase; nasaruplase |
| -ast | Antiasthmatics/antiallergics (not acting primarily as antihistamines; leukotriene biosynthesis inhibitors) | |
| subgroups: |
| -lukast | Antiasthmatics/antiallergics; leukotriene receptor antagonists | cinalukast; pobilukast |
| -milast | Antiasthmatics/antiallergics; type IV phosphodiesterase inhibitors | piclamilast |
| -trodast | Antiasthmatics/antiallergics; thromboxane A2 receptor antagonists | seratrodast |
| -zolast | Antiasthmatics/antiallergics; benzoxazole derivatives | eclazolast; ontazolast |
| -tegr- | Antiasthmatics/antiallergics; integrin antagonists | valategrast |
| -astine | Antihistaminics (histamine-H1 receptor antagonists) | ebastine |
| -(a)tadine | Tricyclic histaminic-H1 receptor antagonists, loratadine derivatives | desloratadine; rupatadine; somantadine |
| -atadine | Tricyclic antiasthmatics | olopatadine; loratadine |
| -axine | Antianxiety, antidepressant inhibitor of norepinephrine and dopamine re-uptake | |
| subgroup: |
| -(f)axine | | radafaxine |
| -azenil | Benzodiazepine receptor agonists/antagonists | bretazenil; flumazenil |
| -azepam | Antianxiety agents (diazepam type) | lorazepam |
| -azepide | Cholecystokinin receptor antagonists | devazepide |
| -azocine | Narcotic antagonists/agonists (6,7-benzomorphan derivatives) | quadazocine; ketazocine |
| -azoline | Antihistamines/local vasoconstrictors (antazoline type) | antazoline |
| -azosin | Antihypertensives (prazosin type) | doxazosin |
| -bactam | Beta-lactamase inhibitors | sulbactam |
| -bamate | Tranquilizers/antiepileptics (propanediol and pentanediol groups) | meprobamate; felbamate |
| -barb or -barb | Barbituric acid derivatives | phenobarbital; secobarbital; eterobarb |
| -begron | Beta 3 adrenoreceptor agonist | talibegron |
| -bendazole | Anthelmintics (tibendazole type) | cambendazole |
| -berel | Beta estrogen receptor agonist | prinaberel |
| -bersat | Anticonvulsants; antimigraine (benzoylamino-benzpyran derivatives) | carabersat; tidembersat |
| bol- or -bol- | Anabolic steroids | bolandiol; mibolerone |
| -bufen | Non-steroidal anti-inflammatory agents, fenbufen derivatives | indobufen |
| -bulin | Antineoplastics (mitotic inhibitors; tubulin binders) | mivobulin |
| -butan | Antiseptics (dapabutan type) | dapabutan; lopobutan |
| -butazone | Anti-inflammatory analgesics (phenylbutazone type) | mofebutazone |
| -caine | Local anesthetics | dibucaine |
| calci- or -calci- | Vitamin D analogues | calcipotriene; tacalcitol |
| -camra | Antivirals (intracellular adhesion molecules, icam-1 derivatives) | tremacamra |
| -camsule | Camphorsulfonic acid derivatives used as UVA sunscreens | ecamsule |
| -casan | Caspase (interleukin –1b) converting enzyme inhibitors | pralnacasan |
| -caserin | Serotonin receptor agonists, primarily 5-HT2 | lorcaserin; vabicaserin |
| -castat | (see -stat) | |
| -carbef | Antibiotics (carbacephem derivatives) | loracarbef |
| -catib | Cathespin inhibitors | balicatib |
| -cavir | (see -vir) | |
| cef- | Cephalosporins | cefazolin |
| -cept | Receptor molecules, native or modified ( a preceding infix should designate the target) | alvircept |
| subgroups: |
| -co- | Receptor molecules, native or modified;complement receptors | mirococept |
| -facept | Receptor molecules, native or modified;lymphocyte function-associated with antigen 3 (LFA) receptor | alefacept |
| -farcept | Receptor molecules, native or modified; interferon receptors | pifarcept |
| -lefacept | Receptor molecules, native or modified; lymphocyte function-associated antigen 3 | alefacept |
| -nercept | Receptor molecules, native or modified; tumor necrosis factor receptors | lenercept |
| -vircept | Receptor molecules, native or modified; antiviral receptors | alvircept |
| -cet | Receptors (small molecule) | |
| subgroup: |
| -calcet | Receptors (small molecule); calcium | tecalcet |
| -cetrapib | Cholesterol ester transfer protein inhibitors | torcetrapib |
| -cic | Hepatoprotectives (timonacic type) | limazocic |
| -ciclib | Cyclin dependent kinase inhibitors | seliciclib |
| -ciclovir | (see -vir) | |
| -cidib | Cyclin dependent kinase inhibitor | alvocidib |
| -cidin | Natural antibiotics (undefined group) | gramicidin |
| -ciguat | Guanaline cyclase activator | ataciguat; atriciguat |
| -cillin | Penicillins | ampicillin |
| -citabine | Nucleoside antiviral or antineoplastic agents, cytarabine or azarabine derivatives | gemcitabine; fiacitabine; zalcitabine |
| -clidine | Muscarinic agonists (various indications) | vedaclidine; talsaclidine |
| -clone | Hypnotics/tranquilizers (zopiclone type) | pagoclone |
| -cog | Blood coagulation factors | |
| subgroups: |
| -eptacog | Blood coagulation factors; blood coagulation factor VII | eptacog alfa (activated) |
| -nonacog | Blood coagulation factors; blood coagulation factor IX | nonacog alfa |
| -octocog | Blood coagulation factors; blood coagulation factor VIII | moroctocog alfa; octocog alfa |
| -cogin | Blood coagulation cascade inhibitor | tifacogin |
| -conazole | Systemic antifungals (miconazole type) | fluconazole; oxiconazole |
| -cort- | Cortisone derivatives | hydrocortisone |
| -coxib | Cyclooxygenase-2 inhibitors | celecoxib; parecoxib; valdecoxib |
| -cridar | (see -dar) | |
| -crinat | Diuretics (ethacrynic acid derivatives) | brocrinat |
| -crine | Acridine derivatives | amsacrine; quinacrine |
| -cromil | Antiallergics (cromoglicic acid derivatives) | nedocromil |
| -curium (also -curonium) | Neuromuscular blocking agents (quaternary ammonium compounds) | atracurium; alcuronium; pipecuronium |
| -cycline | Antibiotics (tetracycline derivatives) | minocycline |
| -dan | Positive inotropic agents (pimobendan type) | prinoxodan; indolidan |
| -dapsone | Antimycobacterials (diaminodiphenylsulfone derivatives) | acedapsone |
| -dar | Multidrug resistance inhibitors | |
| subgroups: |
| -cridar | Multidrug resistance inhibitors;acridine carboxamide derivatives | elacridar |
| -icodar | Multidrug resistance inhibitors;pipecolic acid derivatives | biricodar |
| -quidar | Multidrug resistance inhibitors; quinoline derivatives | lamiquidar; zozuquidar |
| -spodar | Multidrug resistance inhibitors; ciclosporin D derivatives | valspodar |
| -denoson | Adenosine A receptor agonists | tecadenoson; binodenoson |
| -dermin | (see -ermin) | |
| dil-, -dil- or -dil | Vasodilators (undefined group) | fostedil |
| -dipine | Phenylpyridine vasodilators (nifedipine type) | darodipine; felodipine |
| -dismase | (see -ase) | |
| -distim | (see -stim) | |
| -ditan | Antimigraine (5-HT1 receptor agonists) | alniditan |
| -dopa | Dopamine receptor agonists | levodopa |
| -dore | Dopamine D2D3 receptor modulators | aplindore fumarate |
| -dotin | Synthetic analogs of the dolastatin series | tasidotin HCl |
| -dralazine | Antihypertensives (hydrazine-phthalazines) | hydralazine; endralazine |
| -dronate | Calcium metabolism regulators | etidronate; tiludronate |
| -dutant | (see -tant) | |
| -ectedin | Ecteinascodin derivatives | monectedin |
| -ectin | Antiparasitics (ivermectin type) | doramectin; moxidectin |
| -elestat | (see -stat) | |
| -elvakin | (see -kin) | |
| -emcinal | Erythromycin derivatives lacking antibiotic activity | mitemcinal |
| -entan | Endothelin receptor antagonists | bosentan |
| -eptacog | (see -cog) | |
| -eptakin | (see -kin) | |
| -erg- | Ergot alkaloid derivatives | pergolide |
| -eridine | Analgesics (meperidine type) | anileridine |
| -ermin | Growth factors | |
| subgroups: |
| -bermin | Growth factors; vascular endothelial growth factors | telbermin |
| -dermin | Growth factors; epidermal growth factors | murodermin |
| -fermin | Growth factors; fibroblast growth factors | ersofermin |
| -nermin | Growth factors; tumor necrosis factors | sonermin; tasonermin |
| -plermin | Growth factors; platelet derived growth factors | becaplermin |
| -sermin | Growth factors; insulin-like growth factors | mecasermin |
| -termin | Growth factors; transforming growth factors | cetermin |
| sub subgroups: |
| -otermin | Growth factors; bone morphogenetic proteins | dibotermin alfa |
| estr- or -estr- | Estrogens | estrone; fenestrel |
| subgroups: |
| -estrant | Estrogen antagonists | fulvestrant |
| -etanide | Diuretics (piretanide type) | bumetanide |
| -exakin | (see -kin) | |
| -ezolid | Oxazolidinone antibacterials | eperezolid; linezolid |
| -farnib | Farnesyl transferase inhibitor | tipifarnib |
| -fenamate | "fenamic acid" ester or salt derivatives | etofenamate |
| -fenamic acid | Anti-inflammatory agents (anthranilic acid derivatives) | flufenamic acid |
| -fenin | Diagnostic aids ((phenylcarbamoyl)methyl iminodiacetic acid derivatives) | arclofenin |
| -fenine | Analgesics (fenamic acid subgroup) | floctafenine |
| -fentanil | Narcotic analgesics (fentanyl derivatives) | alfentanil; mirfentanil; brifentanil |
| -fentrine | Phosphodiesterase inhibitor | pumafentrine |
| -fermin | (see -ermin) | |
| -fetamin(e) | Amfetamine derivatives | levmetamfetamine |
| -fiban | Fibrinogen receptor antagonists (glycoprotein IIb/IIIa receptor antagonists) | lamifiban; tirofiban |
| -fibatide | (see -tide) | |
| -fibrate | Antihyperlipidemics (clofibrate type) | bezafibrate |
| -filcon | Hydrophilic contact lens materials | alphafilcon A; xylofilcon A; mipafilcon A |
| -fingol | Sphingosine derivatives | cedefingol; safingol |
| -flapon | 5-lipoxygenase-activating protein (FLAP) inhibitors | quiflapon |
| -flurane | General inhalation anesthetics (halogenated alkane derivatives) | enflurane |
| -fo- | Phosphoro-derivatives | adefovir |
| -focon | Hydrophobic contact lens materials | trifocon A; pasifocon B; satafoconA |
| -formin | Hypoglycemics (phenformin type) | buformin |
| -fradil | Calcium channel blockers acting as vasodilators | mibefradil |
| -fulven | Antineoplastic, acylfulven derivatives | viridofulven |
| -fungin | Antifungal antibiotics (undefined group) | kalafungin |
| -fylline | Theophylline derivatives | enprofylline; bamifylline; cipamfylline |
| -gab- | Gabamimetics | fengabine |
| gado- | Gadolinium derivatives (principally for diagnostic use) | gadodiamide; gadoteridol;gadobenate |
| -gapil | Neuronal apoptosis inhibitors; GAPDH | omigapil |
| -ganan | Antimicrobial, bactericidal permeability increasing polypeptide | iseganan; pexiganan |
| -gatran | Thrombin inhibitors (argatroban type) | efegatran |
| -gest- | Progestins | megestrol |
| -giline | MAO inhibitors, type B | selegiline |
| -gillin | Antibiotics (Aspergillus strains) | mitogillin |
| gli- | Antihyperglycemics | gliflumide |
| -gliptin | Antihyperglycemics; dipeptidyl aminopeptidase-IV inhibitors | vildagliptin |
| -glitazar | Antihyperglycemics; PPAR agonists (not thiazolidene derivatives) | farglitizar |
| -glitazone | Antihyperglycemics; PPST agonists (thiazolidene derivatives) | ciglitazone; rosiglitazone |
| -glumide | CCK antagonists, antiulcer, anxiolytic agent | amiglumide; itriglumide |
| -golix | GnRH receptor antagonists (nonpeptide) | rupugolix |
| -gosivir | (see -vir) | |
| -gramostim | (see -stim) | |
| -grastim | (see -stim) | |
| -grel- or -grel | Platelet aggregation inhibitors (undefined group) | itazigrel; dimetagrel; furegrelate |
| guan- | Antihypertensives (guanidine derivatives) | guanoctine |
| -ibat | Ileal bile acid transport inhibitor | barixibat |
| -icam | Anti-inflammatory agents (isoxicam type) | enolicam; tenoxicam |
| -icodar | (see -dar) | |
| -ifen(e) | Antiestrogens of the clomifene and tamoxifen groups | nitromifene; raloxifene; droloxifene |
| -ilide | Class III antiarrhythmic agents | ibutilide; risotilide; dofetilide |
| -imepodib | Inosine monophosphate dehydrogenase inhibitors | merimepodib |
| -imex | Immunostimulants | forfenimex; roquinimex; ubenimex |
| -imibe- | Antihyperlipidaemics, acyl CoA: cholesterol acyltransferase (ACAT) inhibitors | eldacimibe; avasimibe; pactimibe |
| -imod | Immunomodulators | ivarimod; pidotimod |
| subgroup: |
| -mapimod | Immunomodulators; mitogen-activated protein (MAP) kinase inhibitors | dormapimod |
| -imus | Immunosuppressives | tacrolimus; napirimus; gusperimus; sirolimus |
| io- | Iodine-containing contrast media | iodamide |
| -irudin | Anticoagulants (hirudin type) | desirudin |
| -isant | Histamine H3 receptor antagonists | cipralisant |
| -isomide | Antiarrhythmics (disopyramide derivatives) | bidisomide |
| -ium (also -onium) | Quaternary ammonium derivatives | clidinium; disiquonium; polixetonium |
| -ixafor | CXCR4 antagonists | plerixifor |
| -kacin | Antibiotics obtained from Streptomyces kanamyceticus (related to kanamycin) | amikacin |
| -kalant | Potassium channel antagonists | almokalant; terikalant |
| -kalim | Potassium channel agonists | cromakalim; aprikalim |
| -kalner | Opener of large conductance calcium-activated (maxi-k) K+ channels | flindokalner |
| -kef- | Enkephalin agonists (various indications) | metkephamide; casokefamide |
| -kin | Interleukin type substances | |
| subgroups: |
| -decakin | Interleukin type substances; interleukin-10 analogues and derivatives | ilodecakin |
| -dodekin | Interleukin type substances; interleukin-12 analogues and derivatives | edodekin alfa |
| -elvekin | Interleukin type substances; interleukin 11 analogues and derivatives | oprelvekin |
| -eptakin | Interleukin type substances; interleukin 7 analogues and derivatives | |
| -exakin | Interleukin type substances; interleukin 6 analogues and derivatives | atexakin alfa |
| -leukin | Interleukin type substances; interleukin 2 analogues and derivatives | teceleukin; aldesleukin |
| -nakin | Interleukin 1 analogues and derivatives | |
| sub subgroups: |
| -onakin | Interleukin 1 analogues and derivatives; interleukin 1-a analogues and derivatives | pitonakin |
| -benakin | Interleukin 1 analogues and derivatives; iinterleukin 1-b analogues and derivatives | mobenakin |
| -nonakin | Interleukin 1 analogues and derivatives; iinterleukin 9 analogues and derivatives | |
| -octakin | Interleukin 1 analogues and derivatives; iinterleukin 8 analogues and derivatives | emoctakin |
| -penkin | Interleukin 1 analogues and derivatives; iinterleukin 5 analogues and derivatives | |
| -trakin | Interleukin 1 analogues and derivatives; iinterleukin 4 analogues and derivatives | binetrakin |
| -kinra | Interleukin receptor antagonists | |
| subgroup: |
| -nakinra | Interleukin receptor antagonists; interleukin 1 (IL-1) receptor antagonists | anakinra |
| -kiren | Renin inhibitors | ditekiren; terlakiren; zankiren |
| -lazad | Lipid peroxidation inhibitors | tirilazad |
| -leptin | Leptin derivatives | metreleptin |
| -leukin | (see -kin) | |
| -lind | Pro-apoptotic cGMP phosphodiesterase inhibitors | ractalind; dractalind |
| subgroup: |
| -sulind | Pro-apoptotic cGMP phosphodiesterase inhibitors; antineoplastics, sulindac metabolites | exisulind |
| -lipim | Lipoprotein lipase activators | ibrolipim |
| -locib | Antineoplastics that inhibit the formation of 5-LO, LTB4, LTC4, and thromboxane B2 (TxB2); and Activate PPARg nuclear receptors | etalocib |
| -lubant | Leukotriene receptor antagonists (treatment of inflammatory skin disorders) | ticolubant |
| -lukast | (see -ast) | |
| -lutamide | Antiandrogens | bicalutamide; flutamide |
| -lutril | Neutral endopeptidase inhibitors possessing additional endothelin converting enzyme inhibitory activity | daglutril |
| -mab | Monoclonal antibodies | imciromab; abciximab; capromab; dacliximab; detumomab; enlimomab |
| subgroups: |
| -axo- | Monoclonal antibodies; rat-murine hybrid antibodies | |
| -les- | Monoclonal antibodies; infix for inflammatory/infectious lesions | |
| -toxa- | Monoclonal antibodies; toxin as a target | urtoxazumab |
| -mantadine or -mantine | Antivirals/antiparkinsonians (adamantane derivatives) | rimantadine; dopamantine |
| -mastat | (see -stat) | |
| -meline | Cholinergic agonists (arecoline derivatives used in treatment of Alzheimer's disease) | xanomeline |
| -melteon | Selective melatonin receptor agonist | ramelteon |
| -mer | Polymers | cadexomer; carbetimer |
| -mesine | Sigma receptor ligands | igmesine; panamesine |
| -mestane | Antineoplastics (aromatase inhibitors) | plomestane |
| -metacin | Anti-inflammatory agents (indomethacin type) | zidometacin |
| -micin | Antibiotics (Micromonospora strains) | maduramicin; gentamicin |
| -monam | Monobactam antibiotics | gloximonam; oximonam; tigemonam |
| -morelin | (see -relin) | |
| -moren | Non-peptidic growth hormone secretagogues | ibutamoren |
| -mostim | (see -stim) | |
| -motine | Antivirals (quinoline derivatives) | famotine |
| -moxin | Monoamine oxidase inhibitors (hydrazine derivatives) | benmoxin; domoxin |
| -mulin | Antibacterials, pleuromulin derivatives | retapamulin |
| -multin | Mucosal tolerance inductors | ismomultin |
| -mustine | Antineoplastics (chloroethylamine derivatives) | carmustine |
| -mycin | Antibiotics (Streptomyces strains) | lincomycin |
| nab- or -nab- | Cannabinol derivatives | nabazenil; dronabinol |
| -nakalant | Mixed sodium/potassium channel blockers | vernakalant |
| -nakin | (see -kin) | |
| nal- | Narcotic agonists/antagonists (normorphine type) | nalmefene |
| -navir | (see -vir) | |
| -nercept | (see -cept) | |
| -nermin | (see -ermin) | |
| -nertant | Neurotensin receptor antagonists | reminertant |
| -nesib | Kinesin inhibitors | ispinesib |
| -netant | (see -tant) | |
| -neurin | Neurotensin receptor antagonists; neurotropins | abrineurin |
| -nicline | Nicotinic acetylcholine receptor partial agonists/agonists nonsteroidal anti-inflammatory agents (tenidap | altinicline |
| -nidap | Nonsteroidal anti-inflammatory agents (tenidap type) | ilonidap; tenidap |
| -nidazole | Antiprotozoal substances (metronidazole type) | tinidazole |
| nifur- | 5-nitrofuran derivatives | nifuratel; nifuratrone |
| -nil | Benzodiazepine receptor antagonists/agonists | |
| subgroups: |
| -punil | Mitochondrial benzodiazepine receptor (MBR) selective, partial, or inverse agonists (purine derivatives) | emapunil |
| -quinil | Benzodiazepine receptor agonists, also partial or inverse (quinoline derivatives) | lirequinil |
| -nixin | Anti-inflammatory agents (anilinonicotinic acid derivatives) | clonixin |
| -nonacog | (see -cog) | |
| -nonakin | (see -kin) | |
| -octacog | (see -cog) | |
| -octakin | (see -kin) | |
| -olol | Beta-blockers (propranolol type) | timolol; atenolol |
| -olone | Steroids (not prednisolone derivatives) | minaxolone |
| -onide | Topical steroids (acetal derivatives) | amcinonide |
| -opilone | Epothilone | filopilone |
| -orex | Anorexiants | fludorex |
| -orphan | Narcotic antagonists/agonists dextro-(morphinan derivatives) | methorphan; dextrorphan |
| -osuran | Urotensin receptor antagonists | palosuran |
| -otilate | Hepatoprotectants, di-isopropyl-1,3-dithiol- malonate derivatives | mivotilate |
| -oxacin | Antibacterials (quinolone derivatives) | difloxacin; ciprofloxacin |
| -oxan | Alpha-adrenoceptor antagonists (benzodioxane derivatives) | imiloxan |
| -oxanide | Antiparasitics (salicylanilide derivatives) | bromoxanide |
| -oxef | Antibiotics (oxacefalosporanic acid derivatives) | flomoxef |
| -oxetine | Antidepressants (fluoxetine type) | dapoxetine; seproxetine |
| -pafant | Platelet-activating factor antagonists | apafant; dacopafant; tulopafant; lexipafant |
| -pamide | Diuretics (sulfamoylbenzoic acid derivatives) | alipamide |
| -pamil | Coronary vasodilators (verapamil type) | tiapamil |
| -pamine | Dopaminergics (butopamine type) | fosopamine; ibopamine |
| -panel | AMPA receptor antagonists | fanapanel; irumpanel; talampanel |
| -parcil | Antithrombotics | beciparcil; iliparcil |
| -parcin | Glycopeptide antibiotics | avoparcin |
| -parin | Heparin derivatives and low molecular weight (or depolymerized) heparins | heparin; tinzaparin; dalteparin |
| -parinux | Antithrombotyic indirect selective synthetic factor Xa inhibitors | fondaparinux |
| -paroid | Antithrombotics (heparinoid type) | danaparoid; sulparoid |
| peg- | PEGylated compounds | pegcaristim; pegnartograstim;pegvisomant |
| -penem | Antibacterial antibiotics (carbapenem derivatives) | imipenem |
| -penkin | (see -kin) | |
| perflu- | Blood substitutes and/or diagnostics (perfluorochemicals) | perflubron; perflunafene |
| -peridol | Antipsychotics (haloperidol type) | haloperidol |
| -peridone | Antipsychotics (risperidone type) | risperidone; iloperidone; ocaperidone |
| -perone | Antianxiety agents/neuroleptics (4'-fluoro-4-piperidinobutyrophenone derivatives) | duoperone |
| -pezil | Acetylcholinesterase inhibitors used in the treatment of Alzheimer’s disease | icopezil; donepezil |
| -pidem | Hypnotics/sedatives (zolpidem type) | zolpidem; alpidem |
| -pirdine | Cognition enhancers | linopirdine; besipirdine; sibopirdine |
| -pirox | Antimycotics (pyridone derivatives) | ciclopirox |
| -pitant | (see -tant) | |
| -plact | Platelet factor 4 analogs and derivatives | iroplact |
| -pladib | Phospholipase A2 inhibitors | ecopladib |
| -planin | Antibacterials (Actinoplanes strains) | mideplanin; ramoplanin; teicoplanin |
| -platin | Antineoplastics (platinum derivatives) | cisplatin |
| -plasninin | Inhibitors of plasminogen activator inhibitors – type 1 | tiplasninin |
| -plermin | (see -ermin) | |
| -plestim | (see -stim) | |
| -plon | Non-benzodiazepine anxiolytics, sedatives, hypnotics | ocinaplon; zaleplon |
| -poetin | Erythropoietins | epoetin alfa; epoetin beta |
| -porfin | Benzoporphyrin derivatives | verteporfin; temoporfin |
| -pramine | Antidepressants (imipramine type) | lofepramine |
| -prazan | Acid pump inhibitors, not dependent on acid activation | omidaprazan |
| -prazole | Antiulcer agents (benzimidazole derivatives) | omeprazole; disuprazole |
| subgroup: |
| -maprazole | Antiulcer agents (benzimidazole derivatives); acid pump inhibitors | pumaprazole |
| pred-, -pred- or -pred | Prednisone and prednisolone derivatives | prednicarbate; cloprednol; oxisopred |
| -pressin | Vasoconstrictors (vasopressin derivatives) | desmopressin |
| -pride | Sulpiride derivatives | remoxipride; zacopride |
| -pril | Antihypertensives (ACE inhibitors) | enalapril; temocapril; spirapril |
| -prilat | Antihypertensives (ACE inhibitors) (diacid analogs of the -pril entity) | enalaprilat; spiraprilat |
| -prinim | Nootropic agents, purine derivatives | leteprinim |
| -prim | Antibacterials (trimethoprim type) | ormetoprim |
| -prisnil | Selective progesterone receptor modulators (SPRM) | asoprisnil |
| -pristin | Antibacterials, pristinamycin derivatives | quinupristin; efepristin |
| -pristone | Progesterone receptor antagonists | mifepristone |
| -profen | Anti-inflammatory/analgesic agents (ibuprofen type) | flurbiprofen |
| -prost- or -prost | Prostaglandin derivatives | rioprostil; dinoprost |
| -protafib | Protein tyrosine phosphatase 1B inhibitors | ertiprotafib |
| -pultide | (see -tide) | |
| -proget | Nonsteroidal ligand for the progesterone receptor | tanaproget |
| -queside | Cholesterol sequestrants (glycosides) | pamaqueside |
| -racetam | Nootropes (piracetam type) | piracetam |
| -racil | Uracil type antineoplastics | eniluracil; gemeracil; oteracil |
| -relin | Prehormones or hormone-release stimulating peptides subgroups: | nafarelin |
| subgroups: |
| -morelin | Growth hormone-release stimulating peptides | dumorelin |
| -tirelin | Thyrotropin releasing hormone analogues | protirelin |
| -relix | Hormone-release inhibiting peptides aldosterone antagonists (spironolactone type) | detirelix |
| -renone | Aldosterone antagonists (spironolactone type) | canrenone |
| -restat | (see -stat) | |
| -retin- or -retin | Retinol derivatives | etretinate; pelretin |
| -rev | Therapeutic virus | |
| subgroup: |
| -tucirev | Therapeutic virus; tumoricidal | lontucirev |
| -ribine | Ribofuranil derivatives (pyrazofurin type) | loxoribine |
| rifa- | Antibiotics (rifamycin derivatives) | rifapentine; rifampin |
| -rinone | Cardiotonics (amrinone type) | milrinone |
| -rozole | Aromatase inhibitors (imidazole/triazole derivatives) | letrozole; fadrozole; vorozole |
| -rsen | Antisense oligonucleotides | alicaforsen |
| -rubicin | Antineoplastic antibiotics (daunorubicin type) | esorubicin; idarubicin |
| sal-, -sal- or -sal | Anti-inflammatory agents (salicylic acid derivatives) | mesalamine; diflunisal; balsalazide |
| -sartan | Angiotensin II receptor antagonists | losartan; eprosartan |
| -semide | Diuretics (furosemide type) | azosemide |
| -sermin | (see -ermin) | |
| -serod | Serotonin receptor antagonists and partial agonists | piboserod |
| -serpine | Rauwolfia alkaloid derivatives | reserpine |
| -setron | Serotonin 5-HT3 antagonists | ondansetron; granisetron; lurosetron |
| -siban | Oxytocin antagonists | barusiban |
| -sidomine | Antianginals (sydnone derivatives) | pirsidomine; molsidomine; linsidomine |
| som- | Growth hormone derivatives | somatrem; somatropin |
| subgroups: |
| som- -bove | Growth hormone derivatives; bovine somatotropin derivatives | sometribove |
| som- -por | Growth hormone derivatives; porcine somatotropin derivatives | sometripor; somagrepor |
| -sonan | 5-HT1B receptor antagonists | elzasonan |
| -spirone | Anxiolytics (buspirone type) | zalospirone; tiospirone |
| -spodar | (see -dar) | |
| -sporin | Immunosuppressants (cyclosporine type) | geclesporin; oxeclosporin |
| -stat-, -stat | Enzyme inhibitors | |
| subgroups: |
| -castat | Enzyme inhibitors; dopamine beta-hydrolase (DBH) inhibitors | nepicastat |
| -elestat | Enzyme inhibitors; elastase inhibitors | sivelestat |
| -inostat | Enzyme inhibitors; inhibitors of histone deacetylase | dacinostat |
| -mastat | Enzyme inhibitors; antineoplastics (matrix metalloproteinase inhibitors) | batimastat |
| -(a)mostat | Enzyme inhibitors; proteolytic enzyme inhibitors | nafamostat |
| -restat- or -restat | Aldose-reductase inhibitors | ponalrestat; tolrestat |
| -vastatin | Antihyperlipidemics (HMG-CoA inhibitors) | atorvastatin; lovastatin; pravastatin |
| -urestat | Urease inhibitor | benurestat |
| -stat- | Renal dehydropeptidase inhibitor | cilastatin |
| -stat- | Pepsin inhibitor | pepstatin |
| -statin | Renal dehydropeptidase inhibitor pepsin inhibitor | cilastatin; pepstatin |
| -ster- | Steroids (androgens, anabolics) | testosterone |
| -steride | Testosterone reductase inhibitors | epristeride; fenasteride |
| -stigmine | Cholinesterase inhibitors (physostigmine type) | quilostigmine; teserstigmine |
| -stim | Colony-stimulating factors | |
| subgroups: |
| -distim | Colony-stimulating factors; conjugates of two different types of colony-stimulating factors | milodistim |
| -gramostim | Colony-stimulating factors; granulocyte macrophage colony- stimulating factors (GM-CSF) | molgramostim; regramostim; sargramostim; ecogramostim |
| -grastim | Colony-stimulating factors; granulocyte colony-stimulating factors (G-CSF) | filgrastim; lenograstim |
| -mostim | Colony-stimulating factors; macrophage colony-stimulating factors (M-CSF) | mirimostim |
| -plestim | Colony-stimulating factors; interleukin 3 derivatives; pleiotropic colony-stimulating factors | daniplestim |
| -stinel | NMDA receptor antagonists (glycine recognition site) | licostinel |
| -sulam | Antineoplastics, apoptosis inducing sulfonamide | indisulam |
| sulfa- | Antimicrobials (sulfonamides derivatives) | sulfasalazine |
| -sulfan | Antineoplastics, alkylating agents (methanesulfonate derivatives) | busulfan |
| -sulind | (see -lind) | |
| -tant | Tachykinin (neurokinin) receptor antagonists | |
| subgroups: |
| -dutant | Tachykinin (neurokinin) receptor antagonists; NK2 receptor antagonists | saredutant |
| -netant | Tachykinin (neurokinin) receptor antagonists; NK3 receptor antagonists | osanetant |
| -pitant | Tachykinin (neurokinin) receptor antagonists; NK1 receptor antagonists | dapitant; zinapitant; lanepitant |
| -tapide | Microsomal triglyceride transfer protein (MTP) inhibitors | implitapide |
| -taxel | Antineoplastics, taxane derivatives | paclitaxel |
| -tecan | Antineoplastics (camptothecine derivatives) | topotecan; irinotecan |
| -tecarin | Antineoplastics (rebeccamycin derivatives) | becatecarin |
| -tepa | Antineoplastics (thiotepa derivatives) | azetepa |
| -teplase | (see -ase) | |
| -termin | (see -ermin) | |
| -terol | Bronchodilators (phenethylamine derivatives) | albuterol |
| -tesind | Thymidilate synthetase inhibitors (benzindole derivatives) | metesind |
| -texafin | Texaphryn derivatives | motexafin |
| -thiazide | Diuretics (thiazide derivatives) | chlorothiazide |
| -tiapine | Antipsychotics (dibenzothiazepine derivatives) | quitiapine |
| -tiazem | Calcium channel blockers (diltiazem type) | diltiazem; clentiazem; iprotiazem |
| -tibant | Antiasthmatics (bradykinin antagonists) | icatibant |
| -tide | Peptides and glycopeptides | octreotide |
| subgroups: |
| -fibatide | Peptides and glycopeptides; platelet aggregation inhibitors (glycoprotein IIb/IIIa receptor antagonists) | eptifibatide |
| -pultide | Peptides and glycopeptides; peptides used as pulmonary surfactants | sinapultide |
| -tidine | H2-receptor antagonists (cimetidine type) | lupitidine; ranitidine; donetidine |
| -tinib | Tyrosine kinase inhibitors | canertinib; imatinib; mubritinib |
| -tirelin | (see -relin) | |
| -tirome | Antihyperlidaemic, thyromimetic derivatives | anitirome; axitirome |
| -tocin | Oxytocin derivatives | oxytocin |
| -toclax | Antineoplastic, BLC-2 inhibitor | obatoclax |
| -toin | Antiepileptics (hydantoin derivatives) | albutoin |
| -toran | TLR4 receptor antagonists | eritoran |
| -tox(a)- | Toxins | urtoxazumab |
| -traposin | AP2 inhibitors | seltraposin |
| -trexate | Antimetabolites (folic acid derivatives) | methotrexate |
| -trexed | Antineoplastic thymidylate synthetase inhibitors | pemetrexed; ralitrexed; nolatrexed |
| -tricin | Antibiotics (polyene derivatives) | mepartricin |
| -tril -trilat | Endopeptidase inhibitors | candoxatril; candoxatrilat |
| -triptan | Antimigraine agents (5-HT1 receptor agonists) | naratriptan; oxitriptan; sumatriptan |
| -triptyline | Antidepressants (dibenzo[a,d]cycloheptane derivatives) | amitriptyline |
| -troban | Antithrombotics (thromboxane A2 receptor antagonists) | daltroban; sulotroban |
| -trodast | (see -ast) | |
| -troline | Antipsychotics (dopamine D2 antagonists) | carvotroline; gevotroline |
| -trombopag | Thrombopoetin agonists | eltrombopag |
| trop- or -trop- | Atropine derivatives | benztropine |
| -uclin | Mucosal tolerance inhibitors | |
| -uplase | (see -ase) | |
| -uracil | Uracil derivatives used as thyroid antagonists and as antineoplastics | fluorouracil |
| -uridine | Antivirals; antineoplastics (uridine derivatives) | idoxuridine |
| -vaptan | Vasopressin receptor antagonists | conivaptan; relcovaptan |
| -vastatin | (see -stat) | |
| -verine | Spasmolytic agents (papaverine type) | mebeverine |
| vin- or -vin- | Vinca alkaloids | vinepidine; apovincamine |
| vir-, -vir- or -vir | Antiviral substances (undefined group) | ganciclovir; enviradine; viroxime; alvircept; delavirdine |
| subgroups: |
| -amivir | Antiviral substances; neuraminidase inhibitors | zanamivir |
| -cavir | Antiviral substances; carbocyclic nucleosides | lobucavir |
| -cyclovir | Antiviral substances; (acyclovir type) | acyclovir |
| -ciclovir | Antiviral substances; (acyclovir type) | desciclovir; famciclovir; penciclovir |
| -gosivir | Antiviral substances; glucosidase inhibitor | celgosivir |
| -navir | Antiviral substances; HIV protease inhibitors (saquinavir type) | droxinavir; indinavir; ritonavir |
| -virdine | Antiviral substances; (non-nucleoside reverse transcriptase inhibitors; pyridine derivatives) | atevirdine; delevirdine |
| -virenz | Antivirals (non-nucleoside reverse transcriptase inhibitors; benzoxazinone derivatives) | efavirenz |
| -virsen | Antivirals (antisense) | afovirsen; fomivirsen; trecovirsen |
| -vircept | (see -cept) | |
| -virdine | (see -vir) | |
| -virenz | (see -vir) | |
| -virimat | Antiviral, disrupts viral maturation | bevirimat |
| -viroc | CCR5 antagonists | maraviroc |
| subgroup: |
| -criviroc | CCR5 antagonists, immunomodulators | ancriviroc |
| -vudine | Antineoplastics; antivirals (zidovudine group) (exception: edoxudine) | stavudine; lamivudine; alovudine |
| -xaban | Anticoagulant (Factor Xa inhibitor) | tamixaban |
| -xanox | Antiallergic respiratory tract drugs (xanoxic acid derivatives) | tixanox |
| -(x)antrone | Antineoplastics, mitoxantrone derivatives aza-anthracenedione class of antitumor agents | pixantrone |
| -zolamide | Carbonic anhydrase inhibitors | brinzolamide; dorzolamide; sezolamide |
| -zolast | (see -ast) | |
| -zomib | Proteozome inhibitors | bortezomib |
| -zotan | 5-HT1A receptor agonists/antagonists acting primarily as neuroprotectors | robalzotan; sarizotan; ibalzotan; lecozotan |
Post a Comment